These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4338690

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of malignant brain tumors with nitrosoureas.
    Hansen HH, Muggia FM.
    Cancer Chemother Rep; 1971 Apr; 55(2):99-100. PubMed ID: 4330275
    [No Abstract] [Full Text] [Related]

  • 3. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB, Boldrey EB, Enot KJ.
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract] [Full Text] [Related]

  • 4. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD, Hurwitz BS.
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW, Humphrey EW.
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma.
    Thomson JM, Maruyama Y, Schwartz S, Hahn E.
    Radiology; 1971 Oct; 101(1):187-94. PubMed ID: 4329540
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC, DeVita VT, Serpick AA, Canellos GP.
    N Engl J Med; 1971 Aug 26; 285(9):475-9. PubMed ID: 5558887
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL.
    Vopr Onkol; 2007 Aug 26; 53(6):724-9. PubMed ID: 18416147
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of mycosis fungoides with topical nitrosourea compounds.
    Zackheim HS.
    Arch Dermatol; 1972 Aug 26; 106(2):177-82. PubMed ID: 5048217
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [On the pathogenesis of complications of cerebral angiography in several types of neuroectodermal tumors].
    Kornienko VN, Dovgiallo EM.
    Vopr Neirokhir; 1967 Aug 26; 31(2):14-5. PubMed ID: 4298165
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.